Showing results (21-30 of 221) with videos related to
Sort By:
Pageof 23
Expert Opinion on Drug Safety|November 13, 2015
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseasesItishree Trivedi, Stephen B HanauerCurrent Treatment Options in Gastroenterology|November 23, 2019
The Evolving Role of Thiopurines in Inflammatory Bowel DiseaseSaurabh Kapur, Stephen B HanauerThe American Journal of Gastroenterology|March 24, 2011
Assessing response and loss of response to biological therapies in IBDHenit Yanai, Stephen B HanauerClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2004
Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trialsStephen B Hanauer, Ulf StrömbergCurrent Treatment Options in Gastroenterology|June 6, 2007
Acute and chronic megacolonStephen B Hanauer, Arnold WaldJournal of Crohn'S & Colitis|May 13, 2026
Beyond the bowel: three rare complications of upadacitinib therapy in inflammatory bowel diseaseSam Papasotiriou, Stephen B HanauerAdvances in Nutrition (Bethesda, Md.)|May 16, 2014
Chronobiology and obesity: Interactions between circadian rhythms and energy regulationKeith C Summa, Fred W TurekSleep Medicine Clinics|July 19, 2011
The Genetics of Sleep: Insight from Rodent ModelsKeith C Summa, Fred W TurekCurrent Opinion in Gastroenterology|February 11, 2005
Therapy of ulcerative colitisStephen B Hanauer, Miles SparrowThe American Journal of Gastroenterology|December 21, 2002
Infliximab in the treatment of Crohn's disease: a user's guide for cliniciansWilliam J Sandborn, Stephen B HanauerPageof 23